Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liquid biopsy
MedTech
Guardant360-guided breast cancer therapy swaps boost survival
A new study suggests using the Guardant360 CDx test to inform a treatment change could slash the risk of breast cancer progression or death by half.
Andrea Park
Jun 3, 2025 10:00am
PHASE Scientific raises $34M for urine-based diagnostic platform
May 21, 2025 11:15am
Eisai's abandoned Enhertu challenger set to live on at BlissBio
Mar 21, 2025 7:20am
JPM25: Guardant posts 31% sales gain as cancer blood tests grow
Jan 13, 2025 9:19am
Guardant awarded $292M in false advertising suit against Natera
Nov 26, 2024 10:45am
EU court hands Illumina consolation prize over Grail deal
Sep 3, 2024 12:21pm
